Tulavi Therapeutics Expands Indication for allay™ Hydrogel Cap to Smaller Patients, 25 kg and Above

LOS GATOS, Calif., Oct. 7, 2025 /PRNewswire/ -- Tulavi Therapeutics, a private medical technology company focused on advancing surgical solutions that address critical unmet needs in peripheral nerve surgery, today announced an expanded indication for the allay™ Hydrogel Cap.

The new indication broadens access to patients weighing 25 kilograms (55 lbs) and above, extending the reach of allay™ Hydrogel Cap to include smaller patients who may be at risk of symptomatic neuromas due to trauma or amputation.

"Surgeons now have a trusted solution for nerve protection and reducing the risk of symptomatic neuroma formation in patients as small as 25 kg," said Josh Vose MD, CEO of Tulavi Therapeutics. "We are proud to extend the benefits of the allay Hydrogel Cap to this broader population – who suffer the same debilitating injuries as older and larger individuals – so they may benefit equally."

The allay™ Hydrogel Cap is a fully absorbable, sutureless, in situ forming hydrogel device that provides an entirely conforming and protective barrier to the transected nerve, supporting nerve recovery while reducing the risk of symptomatic neuroma formation. Once deployed, the hydrogel cap remains in place for approximately eight months, protecting the nerve and blocking axonal escape during the critical period of symptomatic neuroma development.

This expanded indication reflects Tulavi's mission to bring meaningful innovation to peripheral nerve surgery and underscores the company's commitment to all surgeons and patient populations.

About Tulavi Therapeutics
Tulavi Therapeutics, based in Los Gatos, CA, is a privately held medical device company with a mission to redefine peripheral nerve surgery through innovation designed to meet the unique needs of each nerve. The company's proprietary in situ forming hydrogel technology represents a breakthrough approach to nerve repair and protection, addressing critical unmet needs in peripheral nerve surgery. Tulavi is committed to advancing patient outcomes and improving the standard of care for surgeons treating peripheral nerve conditions.

SOURCE Tulavi Therapeutics, Inc.